This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: National Defense Medical Center. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Szu-Chia Lai: Innovator in Anti-Dengue Virus Antibodies
Introduction
Szu-Chia Lai is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the development of antibodies for the detection and treatment of dengue virus.
Latest Patents
Szu-Chia Lai holds a patent for "Anti-dengue virus antibodies and applications thereof." This invention focuses on serotype-specific antibodies that are crucial for the detection and differentiation of various dengue virus serotypes in biological samples. The patent also outlines methods and kits for detecting the dengue virus, as well as compositions for diagnosing and treating dengue virus disease using these antibodies.
Career Highlights
Szu-Chia Lai is affiliated with the National Defense Medical Center, where he conducts research aimed at improving public health outcomes. His work has the potential to significantly impact the diagnosis and treatment of dengue virus infections.
Collaborations
He collaborates with notable colleagues such as Jiunn-Jye Wey and Meng-Hung Tsai, contributing to a dynamic research environment focused on innovative solutions for viral diseases.
Conclusion
Szu-Chia Lai's work in developing anti-dengue virus antibodies exemplifies the importance of innovation in medical research. His contributions are vital for advancing the detection and treatment of dengue virus, ultimately benefiting public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile